
How Trump's pick for surgeon general uses her big online following to make money
Trump appointments
Social media
Donald Trump
MediaFacebookTweetLink
Follow
President Donald Trump's pick to be the next U.S. surgeon general has repeatedly said the nation's medical, health and food systems are corrupted by special interests and people out to make a profit at the expense of Americans' health.
Yet as Dr. Casey Means has criticized scientists, medical schools and regulators for taking money from the food and pharmaceutical industries, she has promoted dozens of health and wellness products — including specialty basil seed supplements, a blood testing service and a prepared meal delivery service — in ways that put money in her own pocket.
A review by The Associated Press found Means, who has carved out a niche in the wellness industry, set up deals with an array of businesses.
In her newsletter, on her social media accounts, on her website, in her book and during podcast appearances, the entrepreneur and influencer has at times failed to disclose that she could profit or benefit in other ways from sales of products she recommends. In some cases, she promoted companies in which she was an investor or adviser without consistently disclosing the connection, the AP found.
Means, 37, has said she recommends products that she has personally vetted and uses herself. She is far from the only online creator who doesn't always follow federal transparency rules that require influencers to disclose when they have a 'material connection' to a product they promote.
Still, legal and ethics experts said those business entanglements raise concerns about conflicting interests for an aspiring surgeon general, a role responsible for giving Americans the best scientific information on how to improve their health.
'I fear that she will be cultivating her next employers and her next sponsors or business partners while in office,' said Jeff Hauser, executive director of the Revolving Door Project, a progressive ethics watchdog monitoring executive branch appointees.
The nomination, which comes amid a whirlwind of Trump administration actions to dismantle the government's public integrity guardrails, also has raised questions about whether Levels, a company Means co-founded that sells subscriptions for devices that continuously monitor users' glucose levels, could benefit from this administration's health guidance and policy.
Though scientists debate whether continuous glucose monitors are beneficial for people without diabetes, U.S. Health Secretary Robert F. Kennedy Jr. has promoted their use as a precursor to making certain weight-loss drugs available to patients.
The aspiring presidential appointee has built her own brand in part by criticizing doctors, scientists and government officials for being 'bought off' or 'corrupt' because of ties to industry.
Means' use of affiliate marketing and other methods of making money from her recommendations for supplements, medical tests and other health and dietary products raise questions about the extent to which she is influenced by a different set of special interests: those of the wellness industry.
Means earned her medical degree from Stanford University, but she dropped out of her residency program in Oregon in 2018, and her license to practice is inactive. She has grown her public profile in part with a compelling origin story that seeks to explain why she left her residency and conventional medicine.
'During my training as a surgeon, I saw how broken and exploitative the healthcare system is and left to focus on how to keep people out of the operating room,' she wrote on her website.
Means turned to alternative approaches to address what she has described as widespread metabolic dysfunction driven largely by poor nutrition and an overabundance of ultra-processed foods. She co-founded Levels, a nutrition, sleep and exercise-tracking app that can also give users insights from blood tests and continuous glucose monitors. The company charges $199 per year for an app subscription and an additional $184 per month for glucose monitors.
Means has argued that the medical system is incentivized not to look at the root causes of illness but instead to maintain profits by keeping patients sick and coming back for more prescription drugs and procedures.
'At the highest level of our medical institutions, there are conflicts of interest and corruption that are actually making the science that we're getting not as accurate and not as clean as we'd want it,' she said on Megyn Kelly's podcast last year.
But even as Means decries the influence of money on science and medicine, she has made her own deals with business interests.
During the same Megyn Kelly podcast, Means mentioned a frozen prepared food brand, Daily Harvest. She promoted that brand in a book she published last year. What she didn't mention in either instance: Means had a business relationship with Daily Harvest.
Influencer marketing has expanded beyond the beauty, fashion and travel sectors to 'encompass more and more of our lives,' said Emily Hund, author of 'The Influencer Industry: The Quest for Authenticity on Social Media.'
With more than 825,000 followers on Instagram and a newsletter that she has said reached 200,000 subscribers, Means has a direct line into the social media feeds and inboxes of an audience interested in health, nutrition and wellness.
Affiliate marketing, brand partnerships and similar business arrangements are growing more popular as social media becomes increasingly lucrative for influencers, especially among younger generations. Companies might provide a payment, free or discounted products or other benefits to the influencer in exchange for a post or a mention. But most consumers still don't realize that a personality recommending a product might make money if people click through and buy, said University of Minnesota professor Christopher Terry.
'A lot of people watch those influencers, and they take what those influencers say as gospel,' said Terry, who teaches media advertising and internet law. Even his own students don't understand that influencers might stand to benefit from sales of the products they endorse, he added.
Many companies, including Amazon, have affiliate marketing programs in which people with substantial social media followings can sign up to receive a percentage of sales or some other benefit when someone clicks through and buys a product using a special individualized link or code shared by the influencer.
Means has used such links to promote various products sold on Amazon. Among them are books, including the one she co-wrote, 'Good Energy'; a walking pad; soap; body oil; hair products; cardamom-flavored dental floss; organic jojoba oil; a razor set; reusable kitchen products; sunglasses; a sleep mask; a silk pillowcase; fitness and sleep trackers; protein powder and supplements.
She also has shared links to products sold by other companies that included 'affiliate' or 'partner' coding, indicating she has a business relationship with the companies. The products include an AI-powered sleep system and Daily Harvest, for which she curated a 'metabolic health collection.'
On a 'My Faves' page that was taken down from her website shortly after Trump picked her, Means wrote that some links 'are affiliate links and I make a small percentage if you buy something after clicking them.'
It's not clear how much money Means has earned from her affiliate marketing, partnerships and other agreements. Daily Harvest did not return messages seeking comment, and Means said she could not comment on the record during the confirmation process.
Means has raised concerns that scientists, regulators and doctors are swayed by the influence of industry, oftentimes pointing to public disclosures of their connections. In January, she told the Kristin Cavallari podcast 'Let's Be Honest' that 'relationships are influential.'
'There's huge money, huge money going to fund scientists from industry,' Means said. 'We know that when industry funds papers, it does skew outcomes.'
In November, on a podcast run by a beauty products brand, Primally Pure, she said it was 'insanity' to have people connected to the processed food industry involved in writing food guidelines, adding, 'We need unbiased people writing our guidelines that aren't getting their mortgage paid by a food company.'
On the same podcast, she acknowledged supplement companies sponsor her newsletter, adding, 'I do understand how it's messy.'
Influencers who endorse or promote products in exchange for payment or something else of value are required by the Federal Trade Commission to make a clear and conspicuous disclosure of any business, family or personal relationship. While Means did provide disclosures about newsletter sponsors, the AP found in other cases Means did not always tell her audience when she had a connection to the companies she promoted. For example, a 'Clean Personal & Home Care Product Recommendations' guide she links to from her website contains two dozen affiliate or partner links and no disclosure that she could profit from any sales.
Means has said she invested in Function Health, which provides subscription-based lab testing for $500 annually. Of the more than a dozen online posts the AP found in which Means mentioned Function Health, more than half did not disclose she had any affiliation with the company.
Means also listed the supplement company Zen Basil as a company for which she was an 'Investor and/or Advisor.' The AP found posts on Instagram, X and on Facebook where Means promoted its products without disclosing the relationship.
Though the 'About' page on her website discloses an affiliation with both companies, that's not enough, experts said. She is required to disclose any material connection she has to a company anytime she promotes it.
Representatives for Function Health did not return messages seeking comment through their website and executives' LinkedIn profiles. Zen Basil's founder, Shakira Niazi, did not answer questions about Means' business relationship with the company or her disclosures of it. She said the two had known each other for about four years and called Means' advice 'transformational,' saying her teachings reversed Niazi's prediabetes and other ailments.
'I am proud to sponsor her newsletter through my company,' Niazi said in an email.
While the disclosure requirements are rarely enforced by the FTC, Means should have been informing her readers of any connections regardless of whether she was violating any laws, said Olivier Sylvain, a Fordham Law School professor who was previously a senior adviser to the FTC chair.
'What you want in a surgeon general, presumably, is someone who you trust to talk about tobacco, about social media, about caffeinated alcoholic beverages, things that present problems in public health,' Sylvain said, adding, 'Should there be any doubt about claims you make about products?'
Means isn't the first surgeon general nominee whose financial entanglements have raised eyebrows.
Jerome Adams, who served as surgeon general from 2017 to 2021, filed federal disclosure forms that showed he invested in several health technology, insurance and pharmaceutical companies before taking the job — among them Pfizer, Mylan and UnitedHealth Group. He also invested in the food and drink giant Nestle.
He divested those stocks when he was confirmed for the role and pledged that he and his immediate family would not acquire financial interest in certain industries regulated by the Food and Drug Administration.
Vivek Murthy, who served as surgeon general twice, under Presidents Barack Obama and Joe Biden, made more than $2 million in COVID-19-related speaking and consulting fees from Carnival, Netflix, Estee Lauder and Airbnb between holding those positions. He pledged to recuse himself from matters involving those parties for a period of time.
Means has not yet gone through a Senate confirmation hearing and has not yet announced the ethical commitments she will make for the role.
Hund said that as influencer marketing becomes more common, it is raising more ethical questions, such as what past influencers who enter government should do to avoid the appearance of a conflict.
Other administration officials, including Homeland Security Secretary Kristi Noem and Centers for Medicare and Medicaid Services Administrator Dr. Mehmet Oz, have also promoted companies on social media without disclosing their financial ties.
'This is like a learning moment in the evolution of our democracy,' Hund said. 'Is this a runaway train that we just have to get on and ride, or is this something that we want to go differently?'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Washington Post
21 minutes ago
- Washington Post
Direct pay to college athletes starts July 1. Some key dates tied to implementation of settlement
It took five years for the $2.8 billion antitrust lawsuit against the NCAA and five major conferences to reach a settlement. Now comes the process for implementing it. Following are significant dates: Settlement approved; settlement-related NCAA rules are effective, as adopted by the NCAA Division I Board on April 21, 2025. NIL Go portal launches. Opt-in deadline for non-defendant schools to fully commit to revenue sharing. First date for direct institutional revenue-sharing payments to student-athletes. Opt-in schools must 'designate' student-athletes permitted by the settlement to remain above roster limits. With the exception of the 'designated' student-athletes, fall sports must be at or below roster limits by their first day of competition. With the exception of 'designated' student-athletes, winter and spring sports must be at or below roster limits by their first day of competition or Dec. 1, whichever is earlier. ___ AP college sports:
Yahoo
21 minutes ago
- Yahoo
Trump dumps the Federalist Society — and even Republicans are shooketh
In a major about-face, Donald Trump is turning on the conservative powerhouse that built his judicial legacy, the Federalist Society. Yale Law professor Akhil Reed Amar warns that this break with the very group that helped propel him to power marks a dangerous shift. 'He just wants loyalty to himself—thugs and hacks,' Amar says, adding that Federalist Society judges are principled and loyal to the Constitution, not to Trump. 'The Senate needs to play a really important role now—especia


Forbes
22 minutes ago
- Forbes
Musk Follows Harvard In Biting The Hand That Feeds
Elon Musk and Harvard Both Bite the Governmental Hand that Feeds Them From an early age, children are taught essential lessons: do not play with fire, do not pet strange dogs, and if one cannot swim, stay out of the deep end. Another timeless rule—often forgotten by those in positions of immense wealth and influence—is this: do not bite the hand that feeds you. This lesson, while simple, has profound implications in the real world. It applies just as readily to billionaires and institutions as it does to children on a playground. Yet recent actions by both Elon Musk and prominent academic institutions—most notably Harvard, but also Columbia, MIT, and others—suggest that even the most successful individuals and organizations are capable of ignoring foundational wisdom. Harvard set the tone. Amid growing political scrutiny and a shifting cultural landscape, the university has drawn intense criticism over its handling of campus protests, particularly those involving slogans such as 'from the river to the sea.' The administration's decision to defend even the most controversial speech—widely viewed by many as antisemitic—has triggered investigations and jeopardized billions in tax-exempt status and government research funding. This raises a critical question: is this truly the hill worth dying on? Is preserving the right to controversial protest slogans worth risking Harvard's institutional future? It is doubtful that most students and faculty would knowingly trade funding, grants, and prestige for this fight. Elon Musk, the world's richest man, has now followed suit—this time turning his attention toward President Donald Trump, with whom he has launched a high-profile and personal feud. What makes this move especially striking is that President Trump is not a distant figure or a fading influence. He is once again sitting in the White House, wielding executive authority over regulatory agencies, defense contracting, and infrastructure initiatives—all areas that directly affect Musk's companies. Tesla, SpaceX, and xAI have flourished in part because of government partnership. SpaceX alone holds multibillion-dollar contracts with NASA and the Department of Defense. Tesla has benefitted from years of energy subsidies and EV tax incentives. Picking a fight with the sitting president—regardless of personal conviction—puts this entire ecosystem at risk. And again the question must be asked: is this battle worth the damage? Whatever principle Musk may be defending, the consequences extend far beyond himself. Shareholders, employees, and retail investors—many of whom placed their trust and savings in his leadership—are the ones left exposed. The parallel between Harvard and Musk is striking: both have been immensely successful, aided in large part by government funding, favorable regulation, and public goodwill. And both have, for different reasons, chosen to confront the very institutions and leaders that have helped sustain their growth. There is precedent for how this ends. Jack Ma, once the most powerful entrepreneur in China, famously criticized the Chinese government. The backlash was immediate and absolute. His companies were dismantled. His IPO was cancelled. His wealth and influence evaporated almost overnight. Even in less authoritarian systems, the lesson holds: those who antagonize the systems that support them may not survive the consequences. While Musk's personal net worth has dropped from nearly $450 billion to approximately $300 billion, the impact is more symbolic than practical for him. But for millions of investors, employees, and stakeholders, these battles matter. Market volatility, regulatory backlash, and reputational risk all come with tangible financial costs—costs borne not just by Musk himself, but by those who have trusted and invested in his vision. The same applies to Harvard and peer institutions. Their leadership may believe they are standing on principle, but the price of alienating government agencies and key financial backers could reshape the long-term trajectory of these universities. The erosion of public trust, the loss of bipartisan support, and the potential withdrawal of federal funding pose existential threats. Leadership—whether in business or academia—requires more than conviction. It requires judgment, timing, and the discipline to separate personal ideology from institutional responsibility. Founder-led companies often outperform when leaders are focused, visionary, and measured. But when ego replaces strategy, the consequences can be swift and severe. No one is demanding absolute political alignment or silence in the face of controversy. No one is asking Elon Musk to wear a MAGA hat. But his recent actions have been so volatile, so self-destructive, that investors may soon be tempted to hand him something else entirely—a MEGA hat: Make Elon Great Again. In today's polarized environment, the margin for error has narrowed. And for those who owe much of their success to public support—whether in Silicon Valley or the Ivy League—biting the hand that feeds is not just unwise. It is unsustainable. ---------------------------------- Disclosure: Past performance is no guarantee of future results. Please refer to the following link for additional disclosures: Additional Disclosure Note: The author has an affiliation with ERShares and the XOVR ETF. The intent of this article is to provide objective information; however, readers should be aware that the author may have a financial interest in the subject matter discussed. As with all equity investments, investors should carefully evaluate all options with a qualified investment professional before making any investment decision. Private equity investments, such as those held in XOVR, may carry additional risks—including limited liquidity—compared to traditional publicly traded securities. It is important to consider these factors and consult a trained professional when assessing suitability and risk tolerance.